Clinical trial / 2020
Resveratrol supplementation improved cognitive performance and attenuated the decline in cerebrovascular responsiveness in postmenopausal women.
Postmenopausal women aged 45-85 years (n = 129) were randomized to receive placebo or 75 mg trans-resveratrol twice daily for 12 months. Compared to placebo, resveratrol improved overall cognitive performance (P < 0.001) and attenuated the decline in cerebrovascular responsiveness (CVR) to cognitive stimuli (P = 0.038). The attenuation of CVR decline was associated with a reduction of fasting blood glucose (r = -0.339, P = 0.023).
- Study type
- Randomized controlled trial
- Who was studied
- 129 postmenopausal women aged 45-85 years
- What was measured
- Cognition, cerebral blood flow, cerebrovascular responsiveness (CVR), and cardiometabolic markers
THE PAPER
Sustained Cerebrovascular and Cognitive Benefits of Resveratrol in Postmenopausal Women.
Thaung Zaw JJ, Howe PRC, Wong RHX. Nutrients, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.